摘要:
The present disclosure includes a system for use in the treatment of cancer, the system comprising an extracorporeal circulation device comprising a blood circuit and a blood pump to collect and return blood of a subject, and a light irradiation device to irradiate the blood circuit with light, wherein a photosensitive substance is administered to the subject prior to blood collection, or added to blood collected from the subject prior to light irradiation, the blood collected from the subject and irradiated with light is returned to the subject, and the light has an irradiation energy density of 2.5 to 300 J/cm 2 .
摘要:
Provided is a method for measuring ADAs appearing in a patient receiving molecular-targeted therapy with a drug or the like in a simpler and more accurate manner. A method for measuring anti-drug antibodies (ADAs) in an analyte to be measured, the method comprising: (1) a step of providing a sample comprising an analyte to be measured for ADAs, the step comprising adding a corresponding drug to an analyte to be measured for ADAs to prepare a sample with a drug-ADAs immune complex formed; (2) a step of contacting the sample prepared in step (1) with a carrier coated with complement C1q, anti-C3d antibody, or anti-C1q antibody; (3) a step of contacting a labeled or non-labeled antibody to a drug corresponding to the ADAs with the coated carrier prepared in step (2); and (4) a step of quantifying the drug-ADAs immune complex binding to the complement C1q, anti-C3d antibody, or anti-C1q antibody.
摘要:
The present invention relates to a drug-eluting stent whose main body is made of a metal or a polymeric material, the surface of which is coated with a mixture comprising cilostazol and a bioabsorbable polymer, wherein the molecular weight of the bioabsorbable polymer is 40,000 to 600,000.
摘要:
Provided are a pharmaceutical composition for treating or preventing drug-resistant cancer by photodynamic therapy (PDT) that contains 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of these, and a method for treating or preventing drug-resistant cancer using the pharmaceutical composition.
摘要:
Provided is a method for measuring ADAs appearing in a patient receiving molecular-targeted therapy with a drug or the like in a simpler and more accurate manner. A method for measuring anti-drug antibodies (ADAs) in an analyte to be measured, the method comprising: (1) a step of providing a sample comprising an analyte to be measured for ADAs, the step comprising adding a corresponding drug to an analyte to be measured for ADAs to prepare a sample with a drug-ADAs immune complex formed; (2) a step of contacting the sample prepared in step (1) with a carrier coated with complement C1q, anti-C3d antibody, or anti-C1q antibody; (3) a step of contacting a labeled or non-labeled antibody to a drug corresponding to the ADAs with the coated carrier prepared in step (2); and (4) a step of quantifying the drug-ADAs immune complex binding to the complement C1q, anti-C3d antibody, or anti-C1q antibody.
摘要:
A marrow fluid sampling set and a marrow needle, the marrow fluid sampling set comprising a centrifugal separating container for sampling marrow fluid, a cap having a sampling port, and a sampling tube having a connector fitted thereto at both ends, wherein the centrifugal separating container is closed with the cap, the connector at one end of the sampling tube is fitted to the sampling port of the cap, and the connector at the other end of the sampling tube is fitted to the coat of the marrow needle retained in a marrow to sample the marrow fluid, the marrow needle comprising a tubular coat and an inner needle, wherein the inner needle is detachably inserted into the coat so that the tip of the inner needle is projected from the coat, characterized in that a drill blade is formed at the tip of the inner needle and a cutting blade is formed at the tip of the coat.
摘要:
A method for measuring cholesterol in remnant-like lipoprotein in a sample, by a more convenient operation and with high sensitivity, and a reagent for the measurement are provided. A method for measuring cholesterol in remnant-like lipoprotein, the method comprising subjecting a test sample containing lipoproteins to the action of a cholesterol esterase and a cholesterol oxidase or cholesterol dehydrogenase, and measuring the hydrogen peroxide or reduced coenzyme generated by the enzymatic reaction, wherein a surfactant having a benzenesulfonic acid structure in the molecule or a polyacrylic acid-based polymeric surfactant is used.
摘要:
A method whereby microvesicles released from platelets, which have been activated by an artificial procedure in pre-treating a blood-origin sample with albumin, are exclusively removed and microvesicles in the blood alone are measured.